U.S. Project BioShield To Add 2 Vaccines, 2 Treatments For Ebola To National Stockpile
CIDRAP News: Project BioShield adds Ebola vaccines, drugs to U.S. stockpile
“The U.S. Department of Health and Human Services (HHS) has announced the first Project BioShield funding for Ebola countermeasures, which would add two vaccines and two treatments to the Strategic National Stockpile (SNS): a single-dose vaccine licensed by Merck, a prime-boost vaccine regimen from Johnson & Johnson, and monoclonal antibody treatments from Mapp Biopharmaceutical and Regeneron Pharmaceuticals…” (Schnirring, 10/2).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.